Crossmark

Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin

Crossref DOI link: https://doi.org/10.1007/s00520-026-10845-1

Published Online: 2026-06-03

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tokito, Yurie

Ishigaki, Kazunaga

Nara, Katsuhiko

Endo, Go

Nishio, Hiroto

Fukuda, Koshiro

Suzuki, Tatsunori

Sato, Yasuyoshi

Takahara, Naminatsu

Boku, Narikazu

Fujishiro, Mitsuhiro
Funding

Funding for this research was provided by:

The University of Tokyo
License Information

Text and Data Mining valid from 2026-06-01

Version of Record valid from 2026-06-03
More Information

Article History

Received: 24 January 2026

Accepted: 27 May 2026

First Online: 3 June 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below